Primitive AML progenitors from most CD34+ patients lack CD33 expression but progenitors from many CD34- AML patients express CD33

Author： Vercauteren Sm Zapf R. Sutherland Hj

Publisher： Ashgate Publishing Ltd

ISSN： 1465-3249

Source： Cytotherapy, Vol.9, Iss.2, 2007-01, pp. : 194-204

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CD133 (AC133) expression on AML cells and progenitors

By Vercauteren SM Sutherland HJ

Cytotherapy, Vol. 3, Iss. 6, 2001-11 ,pp. : 449-459

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Transduction of CD34⁺ and CD34⁻/lin⁻ Hemopoietic Progenitors by Lentivirus Vectors

By Moriwaki K Sutton RE Perez M Brenner MK Heslop HE

Cytotherapy, Vol. 1, Iss. 6, 1999-01 ,pp. : 433-438

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Ab therapy of AML: native anti-CD33 Ab and drug conjugates

By Jurcic Jg

Cytotherapy, Vol. 10, Iss. 1, 2007-10 ,pp. : 7-12

Ashgate Publishing Ltd

Access to resources Recommend Favorite

CD34⁺ cell enrichment depletes atypical CD30⁺ cells from PBPC grafts in patients with HD

By Blystad AK Torlakovic E Holte H Kvaløy S Lenschow E Kvalheim G

Cytotherapy, Vol. 3, Iss. 4, 2001-07 ,pp. : 295-305

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Individual and synergistic cytokine effects controlling the expansion of cord blood CD34⁺⁺ cells and megakaryocyte progenitors in culture

By Pineault Nicolas Cortin Valéérie Boyer Lucie Garnier Alain Robert Améélie Théérien Cynthia Roy Denis-Claude

Cytotherapy, Vol. 13, Iss. 4, 2011-04 ,pp. : 467-480

Ashgate Publishing Ltd

Access to resources Recommend Favorite